Venus Medicine Research Centre (VMRC) represents the backbone of Venus Remedies Limited (http://www.venusremedies.com). Dedicated to formulations research, this innovation centre develops remedy defining formulations. VMRC focuses on the development of novel solutions that plug the gap between challenging ailments and available molecules. It focuses on critical care and super specialty segment, including anti-infective {Anti-Microbial Resistance (AMR)}, Anticancer, Neurology, Pain Management and Skin & Wound Care.

The Research Centre comprises high-tech testing laboratories, which are at par with stringent cGLP standards. These laboratories cover microbiology, toxicology, molecular biology, biochemistry, pharmacognosy and biotechnology, addressing tissue culture, stability and chemical analyses. The Centre also has a Cell Culture Molecular Biology (CCMB) laboratory, making it one of few Indian pharmaceutical companies with this facility, accelerating the testing cancer drugs.

The Company's research programme is home to over 60 scientists and support staff; 60% of the team comprises PhDs and post-doctorates, while 40% are postgraduates. The R&D team focuses on developing novel solutions that plug gaps between challenging ailments and available molecules in uncluttered therapeutic spaces.

Our work Area:

1. Novel Drug Delivery System (NDDS)

2. Development of novel Antibiotic Resistance Breakers (ARB)

3. Target-based platform technology for Oncology Drug Delivery

4. Developing Diagnostic devices for typhoid and cancer

At VMRC, the team focuses not only on developing a pipeline of niche products that enables the company to stand out of the clutter, but also on quality of filings which facilitates in faster product approvals and nurtures respect for the Company among global regulatory authorities.